The largest database of trusted experimental protocols

Matrigel basement membrane matrix

Manufactured by Corning
Sourced in United States, United Kingdom, Germany

Matrigel Basement Membrane Matrix is a complex mixture of extracellular matrix proteins and growth factors derived from Engelbreth-Holm-Swarm (EHS) mouse sarcoma cells. It functions as a substrate that mimics the extracellular environment found in many tissues, providing a three-dimensional structure to support cell attachment, migration, differentiation, and morphogenesis.

Automatically generated - may contain errors

371 protocols using matrigel basement membrane matrix

1

Fibroblast Reprogramming to iPSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
WT, WT/A82T, and A82T/A82T fibroblasts were reprogrammed using the CytoTune™-iPS 2.0 Sendai Reprogramming Kit (Thermo Fisher Scientific, A16517) in accordance with the manufacturer’s instructions. Briefly, fibroblasts were transduced and plated after 7 days onto Matrigel Basement Membrane Matrix (Corning, 354234) in mTeSR1 medium (STEMCELL Technologies, 85850). iPSC colonies were picked between days 17–28 and maintained in Matrigel Basement Membrane Matrix and mTeSR1 for expansion. R393W/A410S, R65*/Y367C, Y14C/S72P fibroblasts were reprogrammed using the ReproRNA™-OKSGM kit (Stemcell Technologies, 05930) in accordance with the manufacturer’s instructions. Briefly, fibroblasts were plated onto Matrigel Basement Membrane Matrix (Corning, 354234) and transfected with ReproRNA™-OKSGM cocktail. Puromycin selection was carried out 1 day after transfection. iPSC colonies were picked between 20 and 28 days after transfection and maintained in Matrigel Basement Membrane Matrix and mTeSR1 for expansion. Between 1 and 3 clones per genotype were maintained for further experiments.
+ Open protocol
+ Expand
2

Syngeneic Tumor Engraftment and Treatment Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Female C57BL/6 mice (Jackson Laboratories), athymic nude mice (Charles River), mTmG mice in a C57BL/6 background (ROSAmT/mG, Jackson Laboratories), and CD8-knockout mice (B6.129S2-Cd8atm1Mak/J, Jackson Laboratories) between 6 and 8 weeks old were injected with 100,000 A223 cells suspended in PBS and 50% Matrigel Basement Membrane Matrix (Corning) to a final volume of 50 μl subcutaneously on their flank. Rechallenge experiments used the same injection protocol on the opposite flank. Treatment began either at tumor injection (Fig. 1c, d) or when tumors were established and reached a size of 100–200 mm3 after approximately 13 days (all other experiments). Because LY2 cells were derived from an oral SCC, 1,000,000 LY2 cells were injected bucally into Balb/c mice (Jax Laboratories) in 50% Matrigel Basement Membrane Matrix (Corning) to a final volume of 50 μl, and treatment was started when tumors became palpable approximately 5 days post-injection. All mice were maintained under pathogen-free conditions in the vivarium facility of University of Colorado AMC. Tumor length and width were measured with calipers, and prolate ellipsoid tumor volume was calculated as π(length × width2)/6. Animal work was approved by the Institutional Animal Care and Use Committee of the University of Colorado, Anschutz Medical Campus (Aurora, CO).
+ Open protocol
+ Expand
3

Melanocyte Tumor Formation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tumor formation by wild type (sAC FF) and Adcy10−/− (sAC KO) melanocytes (n = 10 per cohort) was performed by injecting into both flanks 5,000,000 cells in 50 μL of 25% Matrigel Basement Membrane Matrix (Corning, #354248). Mice were observed every 3-4 days for tumor formation and tumor size was measured. Mice were euthanized when tumors reached 2 cm. For studies of the effects of cAMP microdomains on tumor growth, NSG mice were injected into the right flank with 5000 cells in 50 μL of 25% Matrigel Basement Membrane Matrix (Corning, #354248). Tumor growth was monitored every 3-4 days and the largest diameter was recorded. When tumors reached 1 cm in diameter, mice were randomized and one cohort was switched to doxycycline diet. When tumors in any cohort reached 2.5 cm in diameter, mice were euthanized, and tumor samples were collected for further analyses. Tumor growth data are presented as a fold change in size, normalized to tumor size on the day when mice were randomized and doxycycline was introduced into the diet. Upon euthanasia, tumors were removed, weighed, and samples were placed in formalin or flash frozen for subsequent analysis. Total number of mice per condition (regular chow/doxycycline chow): NLS-sAC 14/14, NES-sAC 9/9, mito-sAC 10/10, LacZ CTRL 5/5, 5SA-YAP 5/4, S397A-YAP 5/5, WT-YAP 5/5.
+ Open protocol
+ Expand
4

Melanocyte Tumor Formation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tumor formation by wild type (sAC FF) and Adcy10−/− (sAC KO) melanocytes (n = 10 per cohort) was performed by injecting into both flanks 5,000,000 cells in 50 μL of 25% Matrigel Basement Membrane Matrix (Corning, #354248). Mice were observed every 3-4 days for tumor formation and tumor size was measured. Mice were euthanized when tumors reached 2 cm. For studies of the effects of cAMP microdomains on tumor growth, NSG mice were injected into the right flank with 5000 cells in 50 μL of 25% Matrigel Basement Membrane Matrix (Corning, #354248). Tumor growth was monitored every 3-4 days and the largest diameter was recorded. When tumors reached 1 cm in diameter, mice were randomized and one cohort was switched to doxycycline diet. When tumors in any cohort reached 2.5 cm in diameter, mice were euthanized, and tumor samples were collected for further analyses. Tumor growth data are presented as a fold change in size, normalized to tumor size on the day when mice were randomized and doxycycline was introduced into the diet. Upon euthanasia, tumors were removed, weighed, and samples were placed in formalin or flash frozen for subsequent analysis. Total number of mice per condition (regular chow/doxycycline chow): NLS-sAC 14/14, NES-sAC 9/9, mito-sAC 10/10, LacZ CTRL 5/5, 5SA-YAP 5/4, S397A-YAP 5/5, WT-YAP 5/5.
+ Open protocol
+ Expand
5

Transwell Invasion Assay for PC3 and DU145 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Transwells (6-well type, pore size 8 μm) were coated with Corning® Matrigel® Basement Membrane Matrix (Corning, NY, USA) for 2 h in an incubator. PC3 and DU145 cells (5 × 105 cells/well) were seeded to the upper chamber in the absence or presence of HIC and AA in 1% FBS media. The lower chamber was completely filled with FBS medium. After 24 h incubation, the chambers’ membranes were treated with Fixing solution (3.7% paraformaldehyde in PBS) for 10 min. Next, the chambers were washed gently with warm PBS. The membranes with invaded cells were stained with 0.5% crystal violet in 2% EtOH. After 5 min, the membranes were washed with PBS and kept dry at room temperature. Five random fields of the membranes were observed. Invaded cells were calculated based on the average number of cells from five random areas. Data were presented as the percentage of the number of invaded cells based on the vehicle group.
+ Open protocol
+ Expand
6

Murine Basal and Luminal Cell Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
FACS-isolated basal and luminal cells from WT and Pb-Csf1 mice were cultured in Corning® Matrigel® Basement Membrane Matrix (Corning, Tewksbury, MA) with advanced DMEM/F12 supplemented with B27 (Life technologies, Grand Island, NY), 10 mM HEPES, glutamax (Life technologies, Grand Island, NY), penicillin/streptomycin, and the following growth factors: EGF 50 ng/ml (Peprotech, Rocky Hill, NJ), 500 ng/ml recombinant R-spondin1 (Peprotech, Rocky Hill, NJ), 100 ng/ml recombinant Noggin (Peprotech, Rocky Hill, NJ), 200 nM of TGF-β/Alk inhibitor A83-01 (Tocris, Ellisville, MO), and 10 μm Y-27632 (Tocris, Ellisville, MO). Dihydrotestosterone (DHT) (Sigma, St. Louis, MO) was added to a final concentration of 1 nM.
+ Open protocol
+ Expand
7

Proliferating IH Primary Cell Cultures

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary cell lines derived from 6 proliferating IH samples from the 10 patients included in DAB IHC staining were sourced from the Gillies McIndoe Research Institute Tissue Bank, for analysis. These primary cell lines were cultured in Dulbecco’s Modified Eagle Medium (cat# 10569-010; Thermo Fisher Scientific, Waltham, MA) supplemented with 2% Corning Matrigel Basement Membrane Matrix (cat# 354234; Corning, NY), 10% fetal bovine serum (cat# 10091-148; Thermo Fisher Scientific), and 10,000 U penicillin–streptomycin (cat# 15140-122). The commercial cell line 3T3 (cat# CRL-1658; ATCC, Manassas, VA) was used as a positive control.
+ Open protocol
+ Expand
8

3D Glioma Tumor Spheroid Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
After 7 days of Lenti-Vector or Lenti-CCNB2 virus transduction (senescence occurring), the medium was collected and incubated with glioma cells in different groups. 3 days later, for lower layer, 100 μl pre-cooled Corning Matrigel Basement Membrane Matrix (5 mg/ml, Corning Inc., NY, USA) were added in 1well/24 well plate. To solidify the 3D culture Matrigel, the 24 well plates were maintained in 37 °C for 30 min. For upper layer, 1×104 cells (100 μl) mixed with 200 μl pre-cooled Matrigel were filled in the well (37 °C, 30 min). At last, 500 μl conditioned medium of different groups was injected. After incubation for 10 days, 3D tumor spheroids were photographed by an Inverted Fluorescence Microscope (Olympus IX71, Tokyo, Japan) and calculated.
+ Open protocol
+ Expand
9

Quantifying Cell Invasion Potential

Check if the same lab product or an alternative is used in the 5 most similar protocols
The invasive ability of cells was measured using the Corning® Matrigel® Basement Membrane Matrix (cat. no. 356234; Corning Inc., Corning, NY, USA) and a 24-well Transwell chamber (Corning Inc.) according to the manufacturer's protocol. The number of cells that passed through an 8-µm polycarbonate membrane was calculated. The polycarbonate surface of each chamber was covered with 50 µl Matrigel (1:8 dilution) to create an artificial basement membrane. Cells were cultured at 37°C in FBS-free MEM/F12 and RPMI-1640 medium for 24 h. After serum starvation, the cells were seeded at 1×105 cells/well in the upper Transwell chamber, which contained ~200 µl serum-free medium. The lower chamber was filled with 500 µl of the medium supplemented with 10% FBS. After an incubation of 48 h at 37°C, the chambers were fixed at room temperature with paraformaldehyde for 30 min. Cells that had attached to the upper surface of the chambers were removed with a sterile cotton swab, and cells that adhered to the lower surface were stained with 0.1% crystal violet (Guangfu Institute of Superfine Chemical Industry, Tianjin, China) for 20 min at room temperature. The numbers of stained cells were counted using an inverted microscope (Olympus IX 70–142; Olympus Corp.) in 8 random fields. The experiment was repeated 3 times.
+ Open protocol
+ Expand
10

Endothelial Progenitor Cell Tube Formation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
EPCs tube formation assay was evaluated using Corning Matrigel Basement Membrane Matrix (Corning, New York, USA). The Matrigel matrix was melted overnight at 4°C and added into a pre-cooled 96-well plate (50 μl/well), then incubated at 37°C for 1 h to allow coagulation. EPCs in each group were inoculated into wells (2 × 104 cells/well) on top of the solidified Matrigel matrix. Hundred microliter of EGM-2 MV medium with 10% fetal bovine serum was added and the plates incubated for 8 h in an incubator. Tube formation was quantified by counting sprouting microcapillary-like structures with lengths four times their width using an inverted microscope.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!